Home » Topics » Conferences

Conferences
RSS

COL-1492 can be used several times daily without safety concerns

July 13, 1998

PRO-2000 prevents infection by STD pathogens other than HIV

July 13, 1998

Impaired glucose tolerance and diabetes mellitus in AIDS patients treated with protease inhibitors

July 13, 1998

Phase I/II trial data released for P&U protease inhibitor

July 13, 1998

AIDS vaccine combination is safe and immunogenic in seronegative volunteers

July 10, 1998

French group develops new inhibitors of HIV-1 protease dimerization

July 10, 1998

AMD-3100: a potent chemokine CXCR4 antagonist enters clinical testing

July 10, 1998

Anti-HIV peptide T-22 acts as a CXCR4 receptor antagonist

July 10, 1998

Enzo discovery paves the way for antisense therapy of AIDS

July 10, 1998

IL-4 fusion toxin shows potent antitumor activity in murine model of KS

July 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...